Zameer Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZAMEER PHARMS
ZAMEER PHARMS has three approved drugs.
Summary for Zameer Pharms
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Zameer Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zameer Pharms | TROSPIUM CHLORIDE | trospium chloride | TABLET;ORAL | 215781-001 | Feb 16, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zameer Pharms | FLUPHENAZINE HYDROCHLORIDE | fluphenazine hydrochloride | TABLET;ORAL | 215141-003 | Oct 20, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zameer Pharms | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 212630-002 | Nov 29, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
